Labotec is proud to present a complete diagnostic solution to aid South Africa in the wake of the COV-19 pandemic. The range distributed includes premium quality RT-PCR, Antibody Rapid test kits and automated antibody diagnostic tests for use in diagnosing potentially positive COV-19 patients.
FDA / WHO Approved 3-Gene Multiplex RT-PCR Diagnostic Test
Labotec, in collaboration with Liferiver, are distributing a 3-gene multiplex RT-PCR diagnostic test which is both FDA approved and officially backed by the World Health Organization (WHO). These RT-PCR tests use RNA isolated from sputum, swabs or whole blood to determine the level of activity of the viral infection. Using the level of viral activity allows for a wider window of detection for the virus in active infections.
FDA Approved IgG And IgM Rapid Test Kits
For vaccine purpose diagnostics as well as businesses that are reopening, Labotec is now distributing two brands of FDA approved IgG and IgM rapid test kits. Labotec, in collaboration with VWR International, is distributing the Clarity and SureScreen rapid test kits. These fast and accurate diagnostic tools are able to provide repeatable results in under 15 minutes using either whole blood or serum sample types.
Labotec’s response solution to Covid-19 Pandemic
Automated IgG And IgM Serology Based Diagnostic Test and System
For those looking at automated diagnostic tools, Labotec and Accelerate Diagnostics have partnered to distribute automated IgG and IgM serology based diagnostic tests and system. These are the Bio-Check MS-FAST and the Bio-Check SARS-CoV-2 tests. This test is a chemiluminescent assay for the detection of SARS CoV-2-specific combination of IgG and IgM in the serum of patients who meet CDC SARS-CoV-2 clinical criteria. This automated diagnostic tool can provide results of 8 blood, serum, or plasma samples in under 30 minutes and is perfect for vaccine trail experimentation or diagnostic purposes.
The combined power of these diagnostic tools allows for the diagnosis of Covid-19 from Day 1 of infection until even after the infection has dissipated. Contact Labotec to discuss which alternative will be most suitable for testing in various situations across multiple patients and geographies, and help prevent the further spread of COVID-19.